ESOMEPRAZOL Mepha cpr pell 20 mg 60 pce

7680625810159 CH-62581 A02BC05 04.99.0.
ESOMEPRAZOL Mepha cpr pell 20 mg 60 pce
ESOMEPRAZOL Mepha cpr pell 20 mg 60 pce
ESOMEPRAZOL Mepha cpr pell 20 mg 60 pce
1 / 3
google

Details

Product number
6258101
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
esomeprazolum 20 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, talcum, triethylis citras, hypromellosum, sacchari sphaerae corresp. saccharum max. 5.65 mg, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, polyvidonum K 29-32, macrogolum 6000, crospovidonum, natrii stearylis fumaras corresp. natrium 0.035 mg, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto.

Articles (1)

Esomeprazol-Mepha 20 mg, magensaftresistente Tabletten
Magensaftresistente Tabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/07/2024
Patient information leaflet
Français
23/07/2024
Patient information leaflet
Italien
23/07/2024
Professional SmPC
Allemand
23/07/2024
Professional SmPC
Français
23/07/2024
Professional SmPC
Italien
23/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.035 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 38.65
Specialties list
Yes
Generic
Yes
SL addition date: 01/06/2017

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62581
Drug name
Esomeprazol-Mepha, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
A02BC05
Authorization status
Z
Dispensation category
B
First authorization
06/02/2014
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Protonenpumpenblocker

Packaging details

Description (FR)
ESOMEPRAZOL Mepha cpr pell 20 mg 60 pce
Description (DE)
ESOMEPRAZOL Mepha Filmtabl 20 mg 60 Stk
Market launch
06/02/2014
Narcotic (BTM)
No

Original drug

Esomep i.v., Pulver zur Herstellung einer Injektions-/Infusionslösung
CHF 13.65
View original

Other packaging sizes

ESOMEPRAZOL Mepha cpr pell 20 mg 14 pce
14 TABL
View
ESOMEPRAZOL Mepha cpr pell 20 mg 30 pce
30 TABL
View
ESOMEPRAZOL Mepha cpr pell 20 mg 100 pce
100 TABL
View
ESOMEPRAZOL Mepha cpr pell 20 mg bte 100 pce
100 TABL
View